Trials
Search / Trial NCT06419647

Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers

Launched by ILONA MYLLYNIEMI · May 13, 2024

Apply for Trial

Trial Information

Current as of March 12, 2025

Not yet recruiting

Keywords

Alcohol Aud Mood Tracking Ema Emotional Monitoring Alcohol Tracking

ClinConnect Summary

Participants will be recruited through Prolific. All participants will complete a series of demographic and psychometric questionnaires before beginning the study. Participants will also complete some of the psychometric questionnaires (RCQ, GAD-7, PHQ-9) at the end of the study to track any potential changes. Participants will be pre-screened for their motivation using a modified MTSS (Motivation to Stop Smoking) scale. Participants will also be asked to report their primary source of motivation regarding wanting to quit or reduce drinking, in addition to reporting their main goal regardin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Speaking fluent English
  • • being over 18 years of age
  • • High completion rates of previous studies on the Prolific platform
  • • Being located in the United Kingdom
  • • Consuming over 20 UK units of alcohol per week
  • Exclusion Criteria:
  • • Having an ongoing mental health condition

Trial Officials

Valerie Voon, PhD, MD

Study Director

University of Cambridge

About Ilona Myllyniemi

Ilona Myllyniemi is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on rigorous scientific methodology and ethical standards, Myllyniemi oversees a diverse portfolio of clinical trials that span various therapeutic areas. Her expertise in trial design, regulatory compliance, and stakeholder engagement ensures that each study is conducted with the highest level of integrity and efficacy. By fostering collaboration among researchers, healthcare professionals, and participants, Ilona Myllyniemi plays a pivotal role in driving the development of new treatment options and contributing to the advancement of medical science.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0